Aurobindo Pharma Q2 profit jumps 32.7% to Rs 1,126.1 crore on 23.9% revenue growth
Angel One · · AI-summarised by FinFlash
Aurobindo Pharma reported consolidated September-quarter net profit of Rs 1,126.1 crore, up 32.7% from Rs 848.5 crore a year earlier. Revenue from operations climbed 23.9% to Rs 10,263.3 crore from Rs 8,285.7 crore, putting profit growth ahead of the top line. The numbers landed before Thursday's Indian session, when pharma investors were weighing results alongside a stronger global risk mood after US midterms.
So What?
Profit growing faster than sales points to margin improvement, which may support Indian generics sentiment. Watch management commentary on US pricing and the Democratic healthcare agenda.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.